Skip to content
  • Friday, 14 August 2026
  • 11:24 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • GLP-1 Blockbusters Propel Pharma R&D Returns to 7%, Masking Broader Productivity Challenges, Deloitte Report Reveals
Laboratory Automation & Robotics

GLP-1 Blockbusters Propel Pharma R&D Returns to 7%, Masking Broader Productivity Challenges, Deloitte Report Reveals

Lana Keisha Jun 20, 2026 0

After a prolonged period where growth remained uneven in the wake of global disruptions, a pivotal metric for biopharma research…

Read More
Laboratory Automation & Robotics

Pharmaceutical R&D Returns Soar to 7% Driven by GLP-1 Blockbusters, Raising Sustainability Questions for the Industry

Lana Keisha Jun 4, 2026 0

After a period characterized by uneven growth and strategic recalibrations in the wake of global health challenges, a key metric…

Read More
Laboratory Automation & Robotics

Deloitte Report Reveals Pharma R&D Returns Surge to 7% Driven Primarily by GLP-1 Blockbusters, Raising Sustainability Concerns

Lana Keisha May 6, 2026 0

A new report from Deloitte, titled "Navigating the GLP-1 boom," indicates a significant resurgence in biopharma R&D productivity, with the…

Read More
Top pharma companies set sustainability goals, but emissions are still increasingJohns Hopkins Researchers Uncover Liquid Condensate Mechanism Driving Rare Translocation Renal Cell Carcinoma and Potential Therapeutic PathwaysAngelini Pharma Acquires Catalyst Pharmaceuticals for $4.1 Billion to Bolster Rare Disease and Brain Health PortfolioBioengineered Bone Marrow-on-a-Chip Platform Revolutionizes Human Hematopoiesis Research and Drug Toxicity Screening
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactLLMOps in 2026: The 10 Tools Every Team Must HaveThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ